treatearly.org valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /covid-19 Sitemap: | ||
Meta Tags
| Title | COVID-19 Early Treatment |
| Description | CETF’s work featured on 60 The COVID-19 Early Treatment Fund (CETF) is on a mission to ensure rapid funding and successful completion of the most promising outpatient clinical trials that lead to effective early treatments for COVID-19, using existing repurposed drug. They |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 13.248.155.104 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
treatearly.org Valuation
|
US$11,534,718
Last updated: 2023-05-01 11:24:42
treatearly.org has Semrush global rank of 917,604. treatearly.org has an estimated worth of US$ 11,534,718, based on its estimated Ads revenue. treatearly.org receives approximately 1,330,929 unique visitors each day. Its web server is located in United States, with IP address 13.248.155.104. According to SiteAdvisor, treatearly.org is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$11,534,718 |
| Daily Ads Revenue | US$10,648 |
| Monthly Ads Revenue | US$319,423 |
| Yearly Ads Revenue | US$3,833,076 |
| Daily Unique Visitors | 88,729 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| treatearly.org. | A | 3599 | IP: 13.248.155.104 |
| treatearly.org. | A | 3599 | IP: 76.223.27.102 |
| treatearly.org. | NS | 21600 | NS Record: ns-cloud-b3.googledomains.com. |
| treatearly.org. | NS | 21600 | NS Record: ns-cloud-b4.googledomains.com. |
| treatearly.org. | NS | 21600 | NS Record: ns-cloud-b2.googledomains.com. |
| treatearly.org. | NS | 21600 | NS Record: ns-cloud-b1.googledomains.com. |
| treatearly.org. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| treatearly.org. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| treatearly.org. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| treatearly.org. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| treatearly.org. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| treatearly.org. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
HtmlToTextCheckTime:2023-05-01 11:24:42
| About Overview History Scientific Advisors Our Team Donors Testimonials Press Drugs Clinical trials Promising drugs Guiding Principles Take action Donate Find a trial Apply for funding Stay informed Fluvoxamine FAQ Donate Fluvoxamine Phase 3 Trial: How to Enroll In a CETF-sponsored clinical trial, early treatment of COVID-19 with fluvoxamine dramatically reduced hospitalization rates by more than 90%. The Phase 3 trial is now open to anyone in the US. CETF’s work featured on 60 Minutes On Sunday, March 7th, 60 Minutes featured CETF in a story about using Fluvoxamine as an early treatment for COVID-19. Watch Now Medical Breakthrough 75% Camostat Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla See our work featured this Sunday on 60 Minutes The shortest path to getting life back to normal now is with early treatment View more CETF See our work featured this |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Sun, 24 Oct 2021 02:29:48 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://www.treatearly.org/ HTTP/2 200 server: openresty date: Sun, 24 Oct 2021 02:29:49 GMT content-type: text/html content-length: 60272 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-dca17736-DCA, cache-wdc5548-WDC x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1635042589.990356,VS0,VE62 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
treatearly.org Whois Information
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |